The Discovery Labs’ 2.4 million square foot site in King of Prussia, PA provides all the necessary ingredients to accelerate speed to market for cell and gene therapy innovators. The Center for Breakthrough Medicines is a cell and gene therapy contract development and manufacturing organization (CDMO) for plasmid DNA, viral vectors, and cellular therapy products and is located on-site.
Annual BioHealth Capital Region Forum Showcases Robust Growth Across 4th Largest Biopharma Cluster
Published on :The Sixth Annual BioHealth Capital Region Forum brought together industry leaders from across the region who discussed the accomplishments and strengths of the region as its member companies continue to innovate new therapies and medicines in one of the strongest bio-hub regions in the United States.
BHCR Retains #4 Ranking in GEN’s Top 10 U.S. Biopharma Clusters – Here’s Why.
Published on :BHCR Retains #4 Ranking in GEN’s Top 10 U.S. Biopharma Clusters – Here’s Why. “Top 3 By 2023” has been the slogan for the Biohealth Capital Region (BHCR) over the [….]
BioTalk Podcast – Live from the BioHealth Capital Region Forum
Published on :BioTalk Podcast – Live from the BioHealth Capital Region Forum This special episode of BioTalk was recorded live at this year’s fifth annual BioHealth Capital Region Forum, hosted by AstraZeneca [….]